31-Oxo-20-oxa-2,6,11,13-tetrazahexacyclo[19.6.2.12,5.115,19.09,13.024,28]hentriaconta-1(27),9,11,15(30),16,18,21(29),22,24(28),25-decaene-18-carbonitrile

InChIKey	`OBXLXUGOZZWQOW-UHFFFAOYSA-N`
Compound Name	31-Oxo-20-oxa-2,6,11,13-tetrazahexacyclo[19.6.2.12,5.115,19.09,13.024,28]hentriaconta-1(27),9,11,15(30),16,18,21(29),22,24(28),25-decaene-18-carbonitrile
Canonical SMILES	`N#Cc1ccc2cc1Oc1ccc3cccc(c3c1)N1CCC(NCCc3cncn3C2)C1=O`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	4
Pfam Stratification	Cross-Family
Avg pChEMBL	8.19
Source	ChEMBL;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P49354	FNTA	Homo sapiens	Human	PF01239	9.7	pIC50	TTD_MultiTarget
P49356	FNTB	Homo sapiens	Human	PF00432	9.0	IC50	ChEMBL
P53609	PGGT1B	Homo sapiens	Human	PF00432	7.9	IC50	ChEMBL
P08684	CYP3A4	Homo sapiens	Human	PF00067	6.2	IC50	ChEMBL